 | Sanofi Drug Cancer Risk Should Be Studied, Group Says |
| "We believe people are entitled to know that use of Lantus insulin might be associated with greater risk, but this must also be balanced against the ... |
 | Insulin taken by 500000 could up cancer risk |
| Patients taking the long-acting analogue insulin glargine, sold by Sanofi-Aventis under the name Lantus could have a higher risk of developing cancer than ... |
Source : google.com
Posted Under : sanofi aventis lantus, lantus, insulin lantus, analoginsulin, lantus krebs
No comments:
Post a Comment